)
American Shared Hospital Services (AMS) investor relations material
American Shared Hospital Services Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Quarterly revenue reached $8.43 million in Q2 2026, up 19% year-over-year, with first half revenue rising 18% to $15.51 million, driven by Direct Patient Services and international growth, especially in Rhode Island, Peru, and Puebla.
Strategic transformation from equipment leasing to a diversified radiation oncology platform, along with operational improvements, led to higher patient volumes and utilization.
Cash generation was strong, with $4.4 million generated in the first half and cash balance rising over 80% to $6.8 million at June 30, 2026.
Net loss attributable to shareholders increased to $514,000 for Q2 and $1,126,000 for the first half, mainly due to higher legal fees and increased credit loss allowances.
Growth was supported by strategic investments, technology upgrades, and expansion in advanced radiation therapy services.
Financial highlights
Q2 2026 revenue: $8.43 million (up from $7.07 million in Q2 2025); six-month revenue: $15.51 million (up from $13.18 million year-over-year).
Direct Patient Services segment revenue grew 40% to $4.9 million in Q2; first half up 35% to $8.95 million.
Proton Beam Therapy revenue rose 22% to $2.3 million in Q2; $4.3 million for the first half.
Gross margin for Q2 was $1.4 million (down from $1.6 million year-over-year); H1 gross margin: $2.7 million (up from $2.6 million year-over-year).
Q2 net loss per diluted share: $0.07; H1 net loss per diluted share: $0.17 (vs. $0.04 and $0.14 prior year).
Outlook and guidance
Management remains focused on expanding patient access, improving operating efficiencies, and positioning for sustainable long-term growth.
Substantial doubt exists about the company's ability to continue as a going concern due to ongoing covenant defaults and liquidity risks.
The company is pursuing asset sales, additional financing, and strategic investments to address debt maturities and liquidity needs.
Continued strengthening of the balance sheet and capital structure is a priority.
- All agenda items, including Director elections and auditor ratification, were approved.AMS
AGM 2026 - Revenue and margins rose, but debt covenant defaults threaten ongoing operations.AMS
Q1 2026 - Audit fee disclosures for 2024 were corrected; prior proxy votes remain valid unless changed.AMS
Proxy filing - Virtual vote set for June 24, 2026, on directors, pay, incentive plan, and auditor ratification.AMS
Proxy filing - Virtual meeting to vote on directors, executive pay, incentive plan, and auditor ratification.AMS
Proxy filing - 2025 revenue was $28.1M with a net loss of $1.6M amid a shift to direct patient care.AMS
Q4 2025 - Q3 revenue rose 36.3% to $6.99M, but margins fell on higher costs and lower Gamma Knife volumes.AMS
Q3 2024 - Q2 2024 net income surged to $3.6M on 27% revenue growth and a major acquisition gain.AMS
Q2 2024 - Revenue up 32.9% to $28.3M in 2024, led by direct patient services and global expansion.AMS
Q4 2024
Next American Shared Hospital Services earnings date
Next American Shared Hospital Services earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage